Scientists find new agent to fight genetic disorders -- Zorro-Locked Nucleic Acid

Apr 30, 2007

A study to appear in the June 2007 issue of The FASEB Journal describes a new agent, called "Zorro-LNA," which has the potential to stop genetic disorders in their tracks. In the study, researchers from the Karolinska Institute in Stockholm, Sweden, describe how they developed Zorro-LNA to bind with both strands of a gene’s DNA simultaneously, effectively disabling that gene.

This development has clinical implications for virtually every human condition caused by or worsened by dominant defective genes. Examples include: Huntington’s disease, familial high cholesterol, polycystic kidney disease, some instances of glaucoma and colorectal cancer, and neurofibromatosis, among others.

"Zorro-LNA is a new substance that targets DNA and turns off genes," said co-author Edvard Smith of the Karolinska Institute in Sweden. "It has the potential of becoming a new drug for the treatment of human genetic disease."

The findings described in this article significantly raise the possibility that new therapies could arise where defective DNA is deactivated more completely and more thoroughly than ever before. For instance, Zorro-LNA could be used in combination with "RNA interference" (RNAi). Like Zorro-LNA, RNAi has the ability to deactivate genes, but does so by degrading the gene’s RNA. In addition, Zorro-LNA could be used to deactivate certain genes in stem cells, which could eventually lead to the development of new cells, tissues, or organs. The discovery of RNAi was recognized by a Nobel Prize award in 2006 to two American scientists.

"This is a major development in the treatment not only of genetic diseases, but also of acquired diseases when microbes or toxins cause genes to go awry" said Gerald Weissmann, M.D., Editor-in-Chief of The FASEB Journal. "One might say these researchers have found a gene-hunter’s Holy Grail for which scientists have been hunting for many years. Zorro-LNA should give us a new, safe way of blocking the effects of errors in our genetic repertoire."

Source: Federation of American Societies for Experimental Biology

Explore further: Telomere extension turns back aging clock in cultured human cells, study finds

add to favorites email to friend print save as pdf

Related Stories

Standalone wireless info display device an easy fit

5 hours ago

A Latvian team has come up with a good-looking WiFi display device, connecting to the Internet using WiFi, which runs on a high-capacity built-in battery and tracks what's important to you. This is a standalone ...

Technology improves avalanche gear for backcountry skiers

7 hours ago

As outdoor recreation companies increasingly cater to skiers and snowboarders who like to venture beyond the groomed slopes at ski resorts and tackle backcountry terrain, they've put a special emphasis on gear and equipment ...

The elephant poaching business in numbers

7 hours ago

From the pittance paid to local poachers to a multi-billion dollar industry, here are some of the key numbers related to Africa's endangered elephants:

UN moves toward major treaty for ocean biodiversity

7 hours ago

UN member states agreed Saturday to begin negotiations on a treaty to protect marine biodiversity in ocean areas extending beyond territorial waters, in a move heralded by environmental organizations.

Recommended for you

Gene may open door for improved keloid, scar treatment

Jan 23, 2015

Researchers at Henry Ford Hospital in Detroit have identified a gene that may offer a better understanding of how keloid scars develop and potentially open the door to improved treatment for the often painful, ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.